Zacks Investment Research upgraded shares of LifePoint Hospitals Inc. (NASDAQ:LPNT) from a hold rating to a buy rating in a research report report published on Wednesday morning. They currently have $62.00 target price on the stock.

According to Zacks, “LifePoint Hospitals, Inc. is engaged in the operation of general, acute care hospitals in non-urban communities. The company’s general, acute care hospitals usually provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These hospitals also provide diagnostic and emergency services, as well as outpatient and ancillary services including outpatient surgery, laboratory, radiology, respiratory therapy and physical therapy. “

Other equities analysts also recently issued reports about the company. Credit Suisse Group AG restated a buy rating and set a $64.00 price objective on shares of LifePoint Hospitals in a research report on Tuesday, August 30th. Citigroup Inc. restated a buy rating and set a $68.00 price objective on shares of LifePoint Hospitals in a research report on Friday, September 30th. Wolfe Research initiated coverage on LifePoint Hospitals in a research report on Tuesday, October 25th. They set an underperform rating for the company. Bank of America Corp. downgraded LifePoint Hospitals from a neutral rating to an underperform rating and lowered their price objective for the stock from $66.00 to $59.00 in a research report on Wednesday, November 9th. Finally, TheStreet downgraded LifePoint Hospitals from a buy rating to a hold rating in a research report on Thursday, August 25th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and six have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $69.69.

Shares of LifePoint Hospitals (NASDAQ:LPNT) opened at 54.95 on Wednesday. The firm has a 50-day moving average price of $58.34 and a 200 day moving average price of $61.19. LifePoint Hospitals has a 1-year low of $50.60 and a 1-year high of $75.94. The company has a market cap of $2.21 billion, a PE ratio of 18.58 and a beta of 0.95.

LifePoint Hospitals (NASDAQ:LPNT) last posted its earnings results on Friday, October 28th. The company reported $0.94 EPS for the quarter, beating the consensus estimate of $0.84 by $0.10. The firm earned $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. LifePoint Hospitals had a return on equity of 7.02% and a net margin of 1.93%. The business’s quarterly revenue was up 21.1% on a year-over-year basis. During the same period last year, the company earned $0.97 earnings per share. On average, equities analysts anticipate that LifePoint Hospitals will post $3.58 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “LifePoint Hospitals Inc. (LPNT) Upgraded to Buy by Zacks Investment Research” was published by Financial Market News and is owned by of Financial Market News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece of content can be accessed at http://www.financial-market-news.com/lifepoint-hospitals-inc-lpnt-upgraded-to-buy-by-zacks-investment-research/1212535/.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its position in shares of LifePoint Hospitals by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 3,687,641 shares of the company’s stock valued at $241,058,000 after buying an additional 29,951 shares during the last quarter. American Century Companies Inc. raised its stake in shares of LifePoint Hospitals by 19.6% in the second quarter. American Century Companies Inc. now owns 3,629,063 shares of the company’s stock worth $237,232,000 after buying an additional 594,546 shares during the period. Diamond Hill Capital Management Inc. raised its stake in shares of LifePoint Hospitals by 11.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,884,153 shares of the company’s stock worth $111,598,000 after buying an additional 197,892 shares during the period. BlackRock Fund Advisors raised its stake in shares of LifePoint Hospitals by 2.0% in the third quarter. BlackRock Fund Advisors now owns 1,671,550 shares of the company’s stock worth $99,006,000 after buying an additional 32,566 shares during the period. Finally, State Street Corp raised its stake in shares of LifePoint Hospitals by 0.4% in the second quarter. State Street Corp now owns 1,249,947 shares of the company’s stock worth $81,706,000 after buying an additional 4,820 shares during the period. 97.59% of the stock is currently owned by institutional investors.

About LifePoint Hospitals

LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.

5 Day Chart for NASDAQ:LPNT

Get a free copy of the Zacks research report on LifePoint Hospitals (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for LifePoint Hospitals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Hospitals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.